-+ 0.00%
-+ 0.00%
-+ 0.00%

Double Bond Pharmaceutical International notifies availability of press release

PUBT·07/21/2026 12:48:02
Listen to the news
Double Bond Pharmaceutical International notifies availability of press release
  • Double Bond Pharmaceutical International AB released a press statement on SI053 (Temodex) real-world evidence data accepted for presentation at SNO 2026.
  • The Society for Neuro-Oncology annual meeting runs Nov. 12-15, 2026 in Philadelphia; the abstract is due in a Neuro-Oncology journal supplement.
  • Company link: https://mb.cision.com/Main/12720/4307158/3933333.pdf


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Double Bond Pharmaceutical International AB published the original content used to generate this news brief via Cision (Ref. ID: 20260721:BIT:0733:0) on July 21, 2026, and is solely responsible for the information contained therein.